September 17, 2019
Worldwide immunohematology market is predicted to surpass US $2.7 billion by the year 2024, according to the latest research available at Market Study Report LLC, report provides extensively data on market share, growth, trends and forecasts for the period 2018-2024.
Increasing technological advancements in immunohematology along with surging adoption of automated systems for blood testing will drive the immunohematology market. Growing patient preference for automated analyzers and serologic techniques will foster the industry growth.
Considering the technology scope, gel cards immunohematology market is predicted to grow with a CAGR of 6.2% over the forecast timeframe, owing to rising demand for gel cards in antigen detection, cross matching and alloantibody identification. Gel cards are quicker, safer, does not require skilled professionals and reduces interpretive/technical errors, thereby boosting the segmental growth.
Based on product type, immunohematology market from reagents segment was worth US $1.2 billion in 2017 and is predicted to grow substantially over the analysis period. Growing number of modified reagents utilized in blood typing processes and antibody screening will propel the segmental demand.
Speaking of application spectrum, hospitals segment held 54.2% revenue share of immunohematology market in 2017, due to increasing number of emergency cases such as trauma and accidents. Surging adoption of consumables and medical products in hospital settings will contribute towards market growth.
Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1357092/
In terms of regional landscape, the U.S. dominated the immunohematology market and was worth US $616.5 million in 2017. Growing prevalence of hematological disorders like leukemia, thalassemia and sickle cell anemia is the main factor driving the regional market growth. In addition, Germany immunohematology market is predicted to grow with a CAGR of 4.8% by the year 2024. The regional growth is credited to growing number of trauma centers and blood banks in the country.
Prominent players operating in immunohematology market include Beckman Coulter, Thermo Fisher Scientific, Bio-Rad Laboratories, Hologic, Roche Diagnostics, Siemens Healthcare GmbH, Antisel, Grifols, MTC Invitro, Ortho Clinical Diagnostics, Abbott, Becton Dickinson and Immucor.